Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Hemay005
1. 1255909-03-5
2. Hemay005
3. 4qx9bk9e7p
4. Hemay-005
5. Refchem:159992
6. Mufemilast [inn]
7. Unii-4qx9bk9e7p
8. Acetamide, N-(5-((1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-5,6-dihydro-4,6-dioxo-4h-thieno(3,4-c)pyrrol-1-yl)-
9. Mufemilast [who-dd]
10. Orb1687054
11. Chembl5095240
12. Schembl20580068
13. Glxc-26950
14. Da-55763
15. Hy-145583
16. Cs-0376450
17. N-[5-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4,6-dioxothieno[3,4-c]pyrrol-3-yl]acetamide
| Molecular Weight | 466.5 g/mol |
|---|---|
| Molecular Formula | C20H22N2O7S2 |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 8 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 156 |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 813 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Dermatologic Agents
Drugs used to treat or prevent skin disorders or for the routine care of skin.
Phosphodiesterase 4 Inhibitors
Compounds that specifically inhibit PHOSPHODIESTERASE 4.
ABOUT THIS PAGE
62
PharmaCompass offers a list of Mufemilast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mufemilast manufacturer or Mufemilast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mufemilast manufacturer or Mufemilast supplier.
A Mufemilast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mufemilast, including repackagers and relabelers. The FDA regulates Mufemilast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mufemilast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mufemilast supplier is an individual or a company that provides Mufemilast active pharmaceutical ingredient (API) or Mufemilast finished formulations upon request. The Mufemilast suppliers may include Mufemilast API manufacturers, exporters, distributors and traders.
Mufemilast Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mufemilast GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mufemilast GMP manufacturer or Mufemilast GMP API supplier for your needs.
A Mufemilast CoA (Certificate of Analysis) is a formal document that attests to Mufemilast's compliance with Mufemilast specifications and serves as a tool for batch-level quality control.
Mufemilast CoA mostly includes findings from lab analyses of a specific batch. For each Mufemilast CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mufemilast may be tested according to a variety of international standards, such as European Pharmacopoeia (Mufemilast EP), Mufemilast JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mufemilast USP).
